February 1, 2024 - Page 3 of 22

NYSE Companies - February 1, 2024

Glacier Bancorp Completes Acquisition of Community Financial Group, Inc. in Spokane, Washington

KALISPELL, Mont., Feb. 01, 2024 (GLOBE NEWSWIRE) — Glacier Bancorp, Inc. (“Glacier”) (NYSE: GBCI), today announced the completion of its […]

NYSE Companies - February 1, 2024

Gray and Marquee Broadcasting Swap Television Station Assets

ATLANTA, Feb. 01, 2024 (GLOBE NEWSWIRE) — Gray Television, Inc. (“Gray” or the “Company”) (NYSE: GTN) announced today that it […]

NASDAQ Companies - February 1, 2024

Cabaletta Bio Announces FDA Granted Orphan Drug Designation to CABA-201 for Treatment of Myositis

PHILADELPHIA, Feb. 01, 2024 (GLOBE NEWSWIRE) — Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and […]

NASDAQ Companies - February 1, 2024

Travere Therapeutics to Present at the Guggenheim 6th Annual Biotechnology Conference

SAN DIEGO, Feb. 01, 2024 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that company management will present […]

NASDAQ Companies - February 1, 2024

GeneDx to Report Fourth Quarter 2023 Financial Results on Tuesday, February 20, 2024

STAMFORD, Conn., Feb. 01, 2024 (GLOBE NEWSWIRE) — GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic […]

Canadian Stock Exchange News - February 1, 2024

Stem Holdings, Inc. Announces Effectiveness of Reverse Stock Split on February 1, 2024.

BOCA RATON, FL, Feb. 01, 2024 (GLOBE NEWSWIRE) — Stem Holdings, Inc. (the “Company” or “Stem”) (OTC Pink: STMH CSE: […]

NASDAQ Companies - February 1, 2024

Processa Pharmaceuticals Announces Closing of $7.0 Million Public Offering

HANOVER, MD, Feb. 01, 2024 (GLOBE NEWSWIRE) — Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical […]